Appendix B: Panel Roster and Financial Disclosures

Human Papillomavirus

 

MemberInstitutionFinancial Disclosure
CompanyRelationship
Susan Cu-Uvin*The Warren Alpert Medical School of Brown UniversityAIDS Malignancy ConsortiumData Safety Monitoring Board Chair/Member
International Antiviral Society–USAHonoraria
Speaker
UpToDateHonoraria
Author
Mark EinsteinRutgers New Jersey Medical School

AstraZeneca

Inovio Pharmaceuticals

Iovance Biotherapeutics

Johnson & Johnson

Pfizer

VBL Therapeutics

Research Support (paid to institution)

BD

Douglas Pharmaceuticals

Inovio Pharmaceuticals

Merck

PapiVax

PDS Biotechnology

Consulting Fee (paid to institution)
Lauri MarkowitzCenters for Disease Control and PreventionNoneN/A
L. Stewart MassadWashington University School of Medicine in St. LouisNoneN/A
Anna-Barbara MoscickiDavid Geffen School of Medicine at the University of California, Los AngelesMerckAdvisory Board
Joel PalefskyUniversity of California, San Francisco School of MedicineMerckResearch Support (paid to institution)
Elizabeth StierBoston University Medical CenterNoneN/A
John WeiserCenters for Disease Control and PreventionNoneN/A
Timothy WilkinNewYork–Presbyterian/Weill Cornell MedicineMerckScientific Advisory Board
Merck

ViiV Healthcare
Research Support (paid to institution)
* Section Group Lead

Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim.

 

Download Guidelines